KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Exact Sciences (EXAS) over the last 11 years, with Q3 2025 value amounting to -$46.9 million.

  • Exact Sciences' Change in Receivables fell 930491.16% to -$46.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.1 million, marking a year-over-year decrease of 3632.67%. This contributed to the annual value of $46.3 million for FY2024, which is 654.83% up from last year.
  • Exact Sciences' Change in Receivables amounted to -$46.9 million in Q3 2025, which was down 930491.16% from $73.0 million recorded in Q2 2025.
  • Exact Sciences' 5-year Change in Receivables high stood at $73.0 million for Q2 2025, and its period low was -$46.9 million during Q3 2025.
  • In the last 5 years, Exact Sciences' Change in Receivables had a median value of $2.7 million in 2022 and averaged $3.1 million.
  • As far as peak fluctuations go, Exact Sciences' Change in Receivables surged by 64376.88% in 2023, and later crashed by 930491.16% in 2025.
  • Over the past 5 years, Exact Sciences' Change in Receivables (Quarter) stood at -$39.2 million in 2021, then grew by 15.48% to -$33.1 million in 2022, then soared by 109.39% to $3.1 million in 2023, then tumbled by 587.17% to -$15.2 million in 2024, then plummeted by 209.24% to -$46.9 million in 2025.
  • Its last three reported values are -$46.9 million in Q3 2025, $73.0 million for Q2 2025, and $30.1 million during Q1 2025.